Chiesi Farmaceutici S.p.a., headquartered in Parma, Italy, is a global pharmaceutical company specializing in the development and manufacture of innovative inhalation devices. The company focuses on advanced drug delivery systems, including metered dose inhalers and dry powder formulations, aimed at treating respiratory conditions and pulmonary hypertension. Chiesi is committed to research in combination therapies and pharmaceutical compositions, leveraging expertise in aerosol formulation and Rho-kinase inhibitors to enhance patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

342 Patents

#1 in Parma

#18 in Italy

#2,655 in the World

Parma, Italy

Chiesi Farmaceutici S.p.a.

Forward Citations = 1,865

394 inventors:

Elisabetta Armani (57 out of 57 patents)

Gabriele Amari (48 out of 48 patents)

Paolo Chiesi (39 out of 41 patents)

4. Carmelida Capaldi (28 out of 28 patents)

5. Paolo Ventura (25 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chiesi Farmaceutici S.p.a.. Retrieved from https://idiyas.com/company/chiesi-farmaceutici

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

37 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

226 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]